Literature DB >> 29471290

Presence of Kidney Disease as an Outcome Predictor in Patients with Pulmonary Arterial Hypertension.

Laurent Bitker1, Florence Sens1,2,3,4, Cécile Payet3,4, Ségolène Turquier5, Antoine Duclos3,4, Vincent Cottin5,6, Laurent Juillard1,2,7.   

Abstract

BACKGROUND: Pulmonary arterial hypertension (PAH) may lead to right heart failure and subsequently alter glomerular filtration rates (GFR). Chronic kidney disease (CKD, GFR <60 mL/min/1.73 m2) may also adversely affect PAH prognosis. This study aimed to assess how right heart hemodynamics was associated with reduced estimated GFR (eGFR) and the association of CKD with survival in PAH patients.
METHODS: In a prospective PAH cohort (2003-2012), invasive hemodynamics and eGFR were collected at diagnosis (179 patients) and during follow-up (159 patients). The prevalence of CKD was assessed at PAH diagnosis. Variables, including hemodynamics, associated with reduced eGFR at diagnosis and during follow-up were tested in multivariate analysis. The association of CKD with survival was evaluated using a multivariate Cox regression model.
RESULTS: At diagnosis, mean age was 60.4 ± 16.5 years, mean pulmonary arterial pressure was 43 ± 12 mm Hg, and eGFR was 74.4 ± 26.4 mL/min/1.73 m2. CKD was observed in 52 incident patients (29%). Independent determinants of reduced eGFR at diagnosis were age, systemic hypertension, and decreased cardiac index. Independent determinants of reduced eGFR during follow-up were age, female gender, PAH etiology, systemic hypertension, decreased cardiac index, and increased right atrial pressure. Age ≥60 years, female gender, NYHA 4, and CKD at diagnosis were independently associated with decreased survival. The adjusted hazards ratio for death associated with CKD was 1.81 (95% confidence interval [1.01-3.25]).
CONCLUSION: CKD is frequent at PAH diagnosis and is independently associated with increased mortality. Right heart failure may induce renal hypoperfusion and congestion, and is associated with eGFR decrease.
© 2018 S. Karger AG, Basel.

Entities:  

Keywords:  Cardiorenal syndrome; Chronic kidney disease; Heart failure; Hemodynamics; Mortality/Survival; Physiology; Pulmonary hypertension

Mesh:

Year:  2018        PMID: 29471290     DOI: 10.1159/000487198

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  7 in total

1.  Hot topics in the mechanisms of pulmonary arterial hypertension disease: cancer-like pathobiology, the role of the adventitia, systemic involvement, and right ventricular failure.

Authors:  Edda Spiekerkoetter; Elena A Goncharova; Christophe Guignabert; Kurt Stenmark; Grazyna Kwapiszewska; Marlene Rabinovitch; Norbert Voelkel; Harm J Bogaard; Brian Graham; Soni S Pullamsetti; Wolfgang M Kuebler
Journal:  Pulm Circ       Date:  2019-11-20       Impact factor: 3.017

2.  Mid-regional pro-atrial natriuretic peptide and copeptin as indicators of disease severity and therapy response in CTEPH.

Authors:  Steffen D Kriechbaum; Lillith Scherwitz; Christoph B Wiedenroth; Felix Rudolph; Jan-Sebastian Wolter; Moritz Haas; Ulrich Fischer-Rasokat; Andreas Rolf; Christian W Hamm; Eckhard Mayer; Stefan Guth; Till Keller; Stavros V Konstantinides; Mareike Lankeit; Christoph Liebetrau
Journal:  ERJ Open Res       Date:  2020-11-02

3.  Renal protective effect of sodium ferulate on pulmonary hypertension patients undergoing computed tomography pulmonary angiography.

Authors:  Ying Zhao; Haiyan Wang; Jiayu Zhao; Xun Wang; Yanbo Wang; Wei Li; Tingting Song; Guozhen Hao; Xianghua Fu; Xinshun Gu
Journal:  Pulm Circ       Date:  2020-10-26       Impact factor: 3.017

4.  miR-1226-3p Promotes eNOS Expression of Pulmonary Arterial Endothelial Cells to Mitigate Hypertension in Rats via Targeting Profilin-1.

Authors:  Jie Jian; Liang Xia
Journal:  Biomed Res Int       Date:  2021-11-03       Impact factor: 3.411

5.  Retinal vessel changes in pulmonary arterial hypertension.

Authors:  Mariana DuPont; Savanna Lambert; Antonio Rodriguez-Martin; Okaeri Hernandez; Mark Lagatuz; Taygan Yilmaz; Andrew Foderaro; Grayson L Baird; Patricia Parsons-Wingerter; Tim Lahm; Maria B Grant; Corey E Ventetuolo
Journal:  Pulm Circ       Date:  2022-02-15       Impact factor: 2.886

6.  Development of an Electronic Frailty Index for Predicting Mortality and Complications Analysis in Pulmonary Hypertension Using Random Survival Forest Model.

Authors:  Jiandong Zhou; Oscar Hou In Chou; Ka Hei Gabriel Wong; Sharen Lee; Keith Sai Kit Leung; Tong Liu; Bernard Man Yung Cheung; Ian Chi Kei Wong; Gary Tse; Qingpeng Zhang
Journal:  Front Cardiovasc Med       Date:  2022-07-08

7.  Renal Replacement Therapy in Patients With Acute Decompensated Pulmonary Hypertension Admitted to the Intensive Care Unit.

Authors:  Marcos Garcia; Rogerio Souza; Pedro Caruso
Journal:  Cureus       Date:  2022-09-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.